Some Diabetes Drugs Reduce Risk and Symptoms of Alzheimer’s

Dipeptidyl peptidase-4 inhibitors, a class of drug that reduces blood sugar in type 2 diabetes, were associated with less amyloid…

View More Some Diabetes Drugs Reduce Risk and Symptoms of Alzheimer’s

Drug That Slows Progression of ALS May Provide the Same Benefit for People With Alzheimer’s

Riluzole, a drug commonly prescribed to slow the progression of ALS, appears to slow brain metabolic decline and improve cognitive…

View More Drug That Slows Progression of ALS May Provide the Same Benefit for People With Alzheimer’s

Safety of Solriamfetol for Excessive Daytime Sleepiness in Parkinson’s Disease

A new study revealed there is no adverse events or safety concerns were identified in participants with PD treated with…

View More Safety of Solriamfetol for Excessive Daytime Sleepiness in Parkinson’s Disease

Blarcamesine Increases SIGMAR1 Expression, Shows Improvements in Parkinson Disease Dementia

Patients who received high-dose blarcamesine experienced a 14.51-point MDS-UPDRS total score improvement compared to placebo in a phase 2 study…

View More Blarcamesine Increases SIGMAR1 Expression, Shows Improvements in Parkinson Disease Dementia